Telomir Pharmaceuticals Other Current Liabilities

Telomir Pharmaceuticals (TELO) currently reports a other current liabilities of $830K as of March 2026. That compares with $650K in the prior-year period — up 26.8% year over year. Use the charts on this page to explore Telomir Pharmaceuticals's other current liabilities history and peer comparisons.

Telomir Pharmaceuticals's other current liabilities increased from $650K to $830K — a 26.8% year-over-year increase (period ending March 2026). Watching multi-year history on the chart below helps separate one-off swings from a lasting trend.

Telomir Pharmaceuticals reported $830K in other current liabilities as of March 2026. That compares with $650K in the prior-year period — up 26.8% year over year. Absolute dollar amounts are most useful when compared with prior periods, peers, and related line items such as revenue, assets, or liabilities on Stockcircle.

Start with the current other current liabilities of $830K, then check the historical chart for trend and the peer comparison chart for relative positioning. From there, open related valuation or income-statement pages for Telomir Pharmaceuticals, and consider following TELO for alerts when major investors trade the stock.